oxatomide has been researched along with Leucocythaemia in 1 studies
oxatomide: structure; an anti-allergic & an anti-asthmatic
oxatomide : A member of the class of benzimidazoles that is 1,3-dihydro-2H-benzimidazol-2-one substituted by a 3-[4-(diphenylmethyl)piperazin-1-yl]propyl group at position 1. It is an anti-allergic drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oxatomide inhibit P-glycoprotein pump-efflux activity and the binding of [3H]-azidopine to the cell-surface protein P-glycoprotein, in a dose-related manner." | 5.31 | Circumvention of acquired resistance to doxorubicin in K562 human leukemia cells by oxatomide. ( Fujita, R; Furusawa, S; Ishikawa, M; Sasaki, K; Satoh, S; Takayanagi, M, 2001) |
| "Oxatomide inhibit P-glycoprotein pump-efflux activity and the binding of [3H]-azidopine to the cell-surface protein P-glycoprotein, in a dose-related manner." | 1.31 | Circumvention of acquired resistance to doxorubicin in K562 human leukemia cells by oxatomide. ( Fujita, R; Furusawa, S; Ishikawa, M; Sasaki, K; Satoh, S; Takayanagi, M, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishikawa, M | 1 |
| Fujita, R | 1 |
| Furusawa, S | 1 |
| Takayanagi, M | 1 |
| Sasaki, K | 1 |
| Satoh, S | 1 |
1 other study available for oxatomide and Leucocythaemia
| Article | Year |
|---|---|
Circumvention of acquired resistance to doxorubicin in K562 human leukemia cells by oxatomide.
Topics: Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Membrane; Cell | 2001 |